The altered redox balance in ovarian cancers significantly elevates the ROS level, which favors tumor growth by leading to a reduction of macrophage migration and decreasing of CD8+ T-lymphocyte through PD-L1 upregulation (Li et al., 2022). The gene discussed is CD274; the disease is neoplasm.